0:00 Welcome to Onko Life Center Podcast. 0:02 If you have ever logged into a patient portal, uh clicked open a new message from your clinic, and just stared down at a printed sheet of laboratory results, you have probably felt that that sudden cold wave of anxiety. 0:16 Yeah, it's a very common experience. 0:19 You get this document filled with complex acronyms and long columns of numbers. 0:24 And they seem to hold the absolute secrets to your health. 0:29 Seeing those unfamiliar terms on a results sheet can feel deeply unsettling. 0:34 So today, our mission is to demystify that exact experience. 0:38 Specifically, we are going to explore cancer marker blood tests to help you understand what you are actually looking at. 0:45 Because the immediate assumption people make when they see a number outside a standard range is that this number represents a definitive final verdict. 0:54 Which is terrifying for anyone. 0:56 Oh, absolutely. 0:57 But these values actually provide vital, isolated pieces of a much larger diagnostic picture. 1:03 They set the stage for an investigation, but they do not serve as a complete conclusion on their own. 1:09 Okay, so to build a solid foundation for you, we need to define what these substances actually are biologically. 1:16 We hear the term tumor markers all the time, but physically, what are we talking about? 1:21 Aaron Powell Well, they are specific substances. 1:23 Usually we are talking about proteins, hormones, or even uh pieces of DNA that can appear in your blood, your urine, or within your body tissue. 1:32 Aaron Powell And where do they come from? 1:34 Are they always from the uh the abnormal cells themselves? 1:37 Not always, no. 1:39 They originate in a couple of distinct ways. 1:41 Sometimes, yes, they are produced directly by the abnormal cells, but other times they are manufactured by your own body in a biological immune response to a potential threat. 1:51 Aaron Powell I see. 1:52 So it's either the source of the problem or the body's reaction to it. 1:55 Aaron Powell Yeah, that is a good way to look at it. 1:58 And medical science is advancing rapidly beyond just looking for circulating proteins in the blood. 2:04 Newer testing methods are mapping genetic changes and mutations within the actual tissue itself. 2:09 Aaron Powell Which gives a much more precise picture, I assume. 2:12 Aaron Powell It does. 2:14 These genetic markers are becoming standard in modern oncology because they guide very targeted, personalized treatment choices rather than relying on uh broad stroke approaches. 2:24 Aaron Powell To help visualize how this all works, I like to think of the car dashboard warning light. 2:30 When you're driving and the check engine light suddenly illuminates, it acts as an alert system. 2:36 It tells the mechanic that something specific is happening under the hood. 2:40 What's fascinating here is how accurately that dashboard analogy reflects the medical reality. 2:44 Aaron Powell Because that light on the dashboard does not pinpoint the exact broken belt or the leaking hose on its own. 2:51 Yeah, it simply signals that a deeper physical investigation under the hood is required. 2:56 And it is the same with these tests. 2:59 No single marker can reveal every type of cancer on its own. 3:02 So there isn't one universal check engine light for the human body. 3:06 Aaron Powell No, there isn't. 3:08 Just as a single dashboard light cannot diagnose every possible mechanical failure in a vehicle, the presence of these biological substances gives medical professionals a vital clue, but it is never the entire story. 3:19 Aaron Powell And I imagine some markers are more specific than others. 3:23 Aaron Powell Definitely. 3:24 Some markers link very closely to one specific type of cellular behavior. 3:29 They act as a targeted alert. 3:30 Others appear across several different biological disruptions, making them much broader signals. 3:35 Aaron Powell So the presence of the marker prompts the investigation, but it does not conclude the diagnostic process. 3:41 Aaron Powell Yeah. 3:41 That is the most important takeaway here. 3:44 Aaron Powell Since we have established that these markers act like those warning lights, let us look at the specific alerts that correspond to different areas of the body. 3:51 The medical field relies heavily on an alphabet soup of acronyms here. 3:55 Aaron Powell Which is where a lot of that patient portal anxiety comes from. 3:58 It really is. 3:59 So let us start with PSA. 4:01 We hear that one a lot. 4:02 PSA stands for prostate-specific antigen. 4:06 Biologically, it is an enzyme produced by the prostate gland, and its normal job is to help liquefy semen. 4:12 So it's supposed to be there. 4:13 Yes. 4:14 Usually it stays contained within the prostate network. 4:17 But if the cellular architecture of the prostate gets disrupted, whether by an enlarged prostate, an infection, or abnormal cell growth, that enzyme leaks out into the bloodstream. 4:28 Aaron Powell And that's what the test is looking for. 4:30 Yeah. 4:30 When we draw blood, we are measuring how much of that localized enzyme has escaped into general circulation. 4:36 Aaron Powell Okay, then we have CA125. 4:39 That one is heavily associated with ovarian tissue, correct? 4:42 Aaron Powell It is. 4:42 CA125 is a glycoprotein. 4:45 It is essentially a protein with a sugar attached to it. 4:48 And it is found on the surface of many ovarian cancer cells. 4:52 It sheds into the bloodstream. 4:53 Aaron Powell But it's not exclusively found on cancer cells. 4:55 Aaron Ross Powell No, not at all. 4:56 It is also found in normal tissue in the reproductive tract and the lining of the abdomen. 5:01 Any irritation in the abdominal cavity can cause those tissues to shed CA125. 5:06 Aaron Powell Which again points to why it's just a warning light, not a final answer. 5:10 And we see CEA and AFP as well. 5:14 CEA stands for carcinoembryonic antigen. 5:17 The biology behind this one is fascinating because embryonic is right in the name. 5:22 Yeah, this is a protein that is heavily involved in fetal development, but production is supposed to stop before birth. 5:29 So why would it suddenly appear in an adult? 5:31 When cells turn cancerous, particularly in the colon or rectum, they often regress to a more primitive embryonic state of behavior. 5:39 They essentially forget their mature programming and start producing that fetal protein again. 5:43 That is incredible. 5:44 They just revert back to an earlier biological state. 5:47 Aaron Powell They do. 5:48 And AFP, or alpha fetoprotein, works on a very similar mechanism, but is primarily linked to liver cancer. 5:56 It is another protein normally produced by a fetus' liver, which should drop to near zero after birth. 6:02 Aaron Powell Beyond those broad ones, there are markers that focus on very specific systems. 6:07 HE4 is another protein linked to ovarian cancer, I believe. 6:10 Aaron Powell Yes, and CA19-9 is an antigen shed by pancreatic and bile duct cancers. 6:16 Aaron Powell And Beta HCG relates to certain germ cell tumors, which are tumors that begin in the cells that give rise to sperm or eggs. 6:23 Okay, let's unpack this. 6:25 If these markers are so helpful in identifying potential issues across all these different organs, why doesn't a doctor just run a massive comprehensive panel testing for every single marker at once to be absolutely safe? 6:37 I hear that a lot. 6:38 It seems like casting the widest possible net from the very beginning would be the most logical approach to ensure nothing is missed. 6:45 That comprehensive approach might seem intuitive at first, but no single test panel works for every patient. 6:51 Doctors do not rely on a universal scattershot method. 6:55 Aaron Powell Why not though? 6:56 Wouldn't more data always be better? 6:58 Because testing for every possible marker at once would introduce an unmanageable amount of statistical noise. 7:04 Every person has a baseline level of these proteins floating in their system. 7:08 Oh, I see. 7:09 If we test for 50 markers without a specific clinical reason, probability dictates that a few will come back slightly elevated just due to normal biological variance. 7:18 Which leads to a cascade of unnecessary scans, extreme anxiety, and potentially invasive procedures just to chase down a false positive. 7:26 Precisely. 7:27 Instead, your doctor tailor is a very specific, smaller panel based entirely on your actual symptoms, your physical exam, and your personal medical history. 7:35 So it's a targeted approach. 7:37 Very targeted. 7:38 New markers continue to emerge continuously as research advances. 7:42 So physicians must track the data to determine which specific markers have actually been proven useful for a patient's unique biological situation. 7:51 Running an arbitrary, massive panel contradicts the evidence-based approach that is essential for modern diagnostics. 7:58 If a warning light goes on, human nature dictates that we tend to expect the worst. 8:03 When a patient sees an elevated number on a lab report, the immediate reaction is fear. 8:07 But an elevated marker level does not automatically mean a diagnosis is imminent. 8:12 It definitely does not. 8:13 Let us explore the biological mechanisms behind why non-cancerous factors can raise these levels temporarily. 8:20 We are talking about common medical conditions or everyday occurrences. 8:24 Infections, for instance, cause a massive immune system response. 8:27 Yes, when you have an infection, your body undergoes inflammation. 8:31 Inflammation is essentially tissue swelling and increased blood flow as white blood cells rush to the site. 8:36 And that physical swelling changes things at a cellular level. 8:39 It does. 8:40 This physical swelling and tissue remodeling can cause the normal cells in that area to shed more of their surface proteins, like CA125 or PSA, into the bloodstream. 8:50 It is mechanical disruption, not necessarily abnormal cell growth. 8:55 Aaron Powell Liver disease is another major factor here. 8:57 The liver is the body's primary filtration system. 9:00 It is responsible for clearing out old proteins from the blood. 9:03 Yeah. 9:03 So if the liver is compromised by something like hepatitis or cirrhosis, it simply cannot filter the blood as efficiently. 9:10 Aaron Powell Meaning the proteins just build up. 9:12 Exactly. 9:13 Well, the proteins continue to be produced at a normal rate, but they are not being cleared out of the drain, so to speak. 9:18 The blood levels rise, making it look like there is an overproduction problem when it is actually a disposal problem. 9:24 Aaron Powell That makes perfect sense. 9:26 Smoking also introduces thousands of toxins into the body that the lungs and cardiovascular system have to constantly react to. 9:33 That chronic low-grade tissue damage and constant repair cycle can elevate markers like CEA. 9:39 Yeah, chronic irritation is a big factor. 9:41 And even pregnancy, a major biological change, creates massive shifts. 9:45 We mentioned beta HCG earlier in relation to germ cell tumors, but beta HCG is the exact same hormone produced by the placenta during a normal pregnancy. 9:55 It is. 9:56 A germ cell tumor essentially hijacks that specific cellular machinery, producing the pregnancy hormone even when no pregnancy exists. 10:04 This brings us to the confusion surrounding reference ranges and units of measurement. 10:09 You might see a result of 400 on a lab report. 10:12 And a number like 400 means absolutely nothing in a vacuum. 10:15 Because it depends on the context of the test. 10:17 Yes. 10:18 Its meaning depends entirely on knowing the specific marker being tested, the unique units of measurement, whether it is nanograms per milliliter or units per liter, and the specific reference range of the laboratory that processed the sample. 10:32 So values just above a reference range are not automatically abnormal. 10:36 No, they are not. 10:37 Which highlights how crucial the laboratory itself is to the process. 10:41 Different labs use slightly different chemical assays to bind to these proteins. 10:45 They calibrate their massive testing machines differently. 10:48 Aaron Powell So a 400 at one lab might be a 350 at another lab. 10:52 Yeah, it could be. 10:53 This raises an important question regarding how medical professionals track and interpret this data over time. 10:59 A single elevated number on one particular day is rarely a reason for immediate worry, precisely because of those numerous non-cancerous conditions we just outlined. 11:08 Aaron Powell It's just a single data point. 11:09 Exactly. 11:10 The vital importance lies in the concept of consistency, specifically sticking with the same testing laboratory over time. 11:17 Aaron Ross Powell Because if you use lab A in January and lab B in March, any change in the number might just be the difference in how the two labs calibrate their equipment rather than an actual change in your biology. 11:27 Aaron Powell Doctors are looking for steadily rising trends across multiple consecutive tests, not an isolated high reading from a single snapshot in time. 11:36 Aaron Powell So keeping the variables the same is key. 11:39 Sticking with one laboratory ensures that the data points remain comparable. 11:42 It makes it much easier to track meaningful biological changes rather than chasing false fluctuations. 11:47 Aaron Powell If a biological warning light can be triggered by a false alarm, like a standard infection or a history smoking, doctors need a concrete method to get to the actual truth of the patient's condition. 11:59 They do, and they achieve this by combining the marker results with other diagnostic tools. 12:04 They look at imaging scans like CTs or MRIs and conduct a deep review of the patient's medical history. 12:11 All of this indirect evidence eventually points toward a biopsy. 12:15 So what does this all mean? 12:17 With blood tests and genetic markers being so incredibly advanced today, capable of identifying microscopic proteins and specific genetic mutations circulating in the blood, why is a physical biopsy still considered absolutely necessary? 12:32 It's a fair question. 12:33 It feels like the advanced lab tests combined with modern structural imaging should be enough to confirm what is happening. 12:39 While those advanced markers and imaging scans provide excellent and necessary clues, they still represent indirect evidence. 12:50 Yeah. 12:50 The markers come from cells, or they are produced by the body's immune response, circulating systemically. 12:57 They tell us that a biological disruption is occurring somewhere. 13:01 The imaging scan shows the physical location of where that potential problem might be. 13:05 But they don't show the actual cells themselves. 13:08 No. 13:08 A biopsy remains essential because it allows pathologists to examine the actual tissue architecture under a microscope. 13:16 They are looking at the literal shape of the cells, how they are interacting with neighboring tissue, and their specific growth patterns. 13:24 The laboratory test indicates the problem. 13:26 The imaging scan locates it, but examining the physical cells through a biopsy provides the final definitive piece that completes the full diagnostic picture. 13:36 It's the only way to be absolutely certain. 13:39 Yes. 13:40 It allows oncologists to confirm the exact nature, structure, and behavior of the tissue in a way that indirect blood levels and structural imaging simply cannot achieve on their own. 13:50 Up until this point, we have focused entirely on the process of finding the problem and reaching a diagnosis. 13:56 But these markers are utilized heavily long after a diagnosis has been made. 14:01 Oh, they are a massive part of ongoing care. 14:04 They play a crucial role in guiding treatment and managing follow-up. 14:07 Doctors use them to track whether a specific therapy is actually working, or to watch carefully to see if an issue is returned after a period of remission. 14:15 Yeah, oncologists like consultant medical oncologist Dr. 14:18 Christina Engvansai use marker trends alongside imaging scans to track a patient's progress. 14:24 By looking at these trends together, the care plans can then adjust dynamically. 14:29 Because the numbers are constantly changing in response to the treatment. 14:32 The trends in the numbers tell an ongoing story. 14:35 A falling level after treatment begins often signals that the cellular burden in the body is decreasing. 14:41 So the therapy is actively destroying the cells producing that specific protein. 14:45 Yes, but a physician will always seek to confirm this positive trend alongside recent imaging results to ensure the physical tumor is actually shrinking. 14:54 And what if the level is going up? 14:56 An increasing level, by contrast, acts as an early warning system. 15:00 It might prompt closer monitoring or earlier further testing to see if the cells have developed a resistance to the current therapy. 15:08 We also see how a strong family history of certain issues might lead a doctor to order specific marker tests earlier or more frequently than usual, tying into inherited genetic risk. 15:20 Here's where it gets really interesting. 15:22 Your body is constantly providing real-time, dynamic feedback on how it is responding to therapy through the fluctuation of these proteins. 15:31 It is a continuous biological conversation. 15:34 It really is. 15:35 A conversation between the medical treatment and your cellular response, mapped out in the lab data. 15:41 If we connect this to the bigger picture, the entire medical care team relies heavily on these marker trends, but they use them alongside the physical symptoms you are experiencing and your overall physical response. 15:52 Aaron Powell So they aren't just treating the numbers on a page. 15:55 No. 15:55 The markers alone rarely change a treatment plan without other supporting evidence. 16:00 Instead, they act as an internal monitoring system. 16:03 They help the oncologist understand the biological efficacy of the chosen therapy over time. 16:08 Aaron Powell Which keeps the patient's actual well-being at the center of the plan. 16:12 Yes. 16:12 This holistic approach ensures the treatment strategy remains perfectly aligned with how your body is actually responding at the microscopic level. 16:19 Aaron Powell To bring all of this together and recap the core insights we have explored for you today. 16:25 These tests provide highly valuable clues, alerting your physician that further investigation is required, but they are never standalone answers. 16:34 That is the main thing to remember. 16:36 A single elevated number on a lab report is not a reason to panic because numerous non-cancerous conditions, from simple inflammation to liver clearing tissues, can cause those numbers to rise temporarily. 16:48 That's all about the context. 16:50 The trends over time matter far more than an isolated reading. 16:54 And sticking with one specific laboratory provides the most reliable, consistent data to track those trends accurately. 17:00 Finally, these results are always combined with structural imaging scans, your personal medical history, and physical biopsies to reveal the complete diagnostic picture. 17:10 Consider how the human body is constantly broadcasting microscopic data about its internal state through these proteins and genetic markers. 17:18 Every second of every day, your cells are shedding chemical information into your bloodstream. 17:22 It's a massive amount of data. 17:24 It is. 17:25 Medical science is still just scratching the surface of decoding this vast, complex language, turning what used to be invisible biological battles into readable, actionable data. 17:36 Thank you for joining us on this deep dive. 17:38 We hope this exploration helps you feel more confident the next time you review your medical records, knowing that a single warning light is just the beginning of a thorough, careful process. 17:46 Keep learning, keep asking great questions about your health, and remember that those numbers are just one piece of a much larger biological puzzle.
Community discussion